Physiomics PLC Conference Attendance

Data : 07/01/2019 @ 05:00
Fonte : RNS Non-Regulatory
Ativo : Physiomics Plc (PYC)
Cotação : 2.5  0.05 (2.04%) @ 06:05
Cotação Gráfico

Physiomics PLC Conference Attendance

TIDMPYC

Physiomics PLC

07 January 2019

Physiomics plc

("Physiomics") or ("the Company")

Conference attendance

Physiomics to participate in Biotech Showcase partnering conference

Physiomics plc (AIM: PYC), is pleased to announce that it will be attending the Biotech Showcase partnering conference in San Francisco from 7-9 January 2019 during the JP Morgan Healthcare Conference week. During this week, many of the world's most successful biotech and pharmaceutical companies are present in San Francisco to meet with prospective clients and partners. Over three thousand attendees are expected to participate in over seven thousand organised 1-1 meetings. Physiomics has confirmed meetings with oncology companies from around the world interested in finding out more about our Virtual Tumour platform and how it can enhance their drug discovery and development programs.

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

WH Ireland Limited (nomad)

Katy Mitchell

+44 (0) 161 832 2174

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

Notes to Editor

About Physiomics

Physiomics plc (AIM: PYC) is a solutions provider to the R&D based pharmaceutical and biotechnology industry with a focus on oncology. The Company's Virtual Tumour technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Virtual Tumour has been confirmed by over 60 projects, involving over 25 targets and 60 drugs, and has worked with clients such as Merck KGaA, Merck & Co, Bayer and Lilly.

Based in Oxford UK, the Company works with clients worldwide to support their pre-clinical and clinical oncology development programs. Its team of scientists and computer modelling experts provide bespoke solutions encompassing data, analytics and insight.

Physiomics senior management has academic and commercial expertise, including over 90 years collectively of working in oncology and/or computational biology and over 100 publications in peer reviewed journals.

For more information please visit:

www.physiomics-plc.com

www.twitter.com/Physiomics

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAQZLFBKFFEBBQ

(END) Dow Jones Newswires

January 07, 2019 02:00 ET (07:00 GMT)

Physiomics (LSE:PYC)
Gráfico Histórico do Ativo

1 Ano : De Out 2018 até Out 2019

Click aqui para mais gráficos Physiomics.

Physiomics (LSE:PYC)
Gráfico Intraday do Ativo

Hoje : Segunda, 21 de Outubro de 2019

Click aqui para mais gráficos Physiomics.
Seu Histórico Recente
BOV
VALE5
Vale PNA
BOV
IBOV
iBovespa
BOV
PETR4
Petrobras
BOV
IGBR3
IGB SA
FX
USDBRL
Dólar EUA ..
Ações já vistas aparecerão nesta caixa, facilitando a volta para cotações pesquisadas anteriormente.

Registre-se agora para criar sua própria lista de ações customizada.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.
P: V:br D:20191021 10:04:04